InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3050% below fair value
$0.69+0.04 (+5.48%)
Close on Nov 18, 2026Market cap $31.87MP/E –Yield –
InspireMD operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
InspireMD's operating income for the twelve months ending Jun 30, 2026 was -$53.56M. For fiscal 2025 it was -$49.61M. The highest annual figure on record is -$2.72M in fiscal 2009.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.61M | – |
| FY2024 | Dec 31, 2024 | -$33.50M | – |
| FY2023 | Dec 31, 2023 | -$21.14M | – |
| FY2022 | Dec 31, 2022 | -$18.71M | – |
| FY2021 | Dec 31, 2021 | -$14.72M | – |
| FY2020 | Dec 31, 2020 | -$10.38M | – |
| FY2019 | Dec 31, 2019 | -$9.82M | – |
| FY2018 | Dec 31, 2018 | -$7.61M | – |
| FY2017 | Dec 31, 2017 | -$8.23M | – |
| FY2016 | Dec 31, 2016 | -$7.65M | – |
| FY2015 | Dec 31, 2015 | -$14.49M | – |
| FY2013 | Jun 30, 2013 | -$15.07M | – |
| FY2010 | Dec 31, 2010 | -$3.22M | – |
| FY2009 | Dec 31, 2009 | -$2.72M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.45M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.98M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.05M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.02M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.46M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.26M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.81M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.32M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.94M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.61M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.68M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.49M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.93M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.44M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.72M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.20M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.45M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.02M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.51M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.00M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.18M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.13M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.21M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.98M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.47M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.95M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.45M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.09M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.29M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.40M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.09M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.76M | – |
See a number that looks wrong?